Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

Schizophrenia Research

Volumn 52, Issue 1-2, 2001, Pages 115-120

  Laakso, Aki ^a   Bergman, Jörgen ^b   Haaparanta, Merja ^b   Vilkman, Harry ^a   Solin, Olof ^b   Syvälahti, Erkka ^a   Hietala, Jarmo ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU PET CENTRE   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

CFT; Dopamine transporter; Positron emission tomography; Schizophrenia; WIN 35,428

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; BENZODIAZEPINE DERIVATIVE; BIPERIDEN; CHLORPROTHIXENE; DOPAMINE TRANSPORTER; HALOPERIDOL; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE; THIORIDAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG BINDING; HUMAN; NERVE ENDING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PUTAMEN; SCHIZOPHRENIA;

ADULT; BRAIN MAPPING; CHRONIC DISEASE; COCAINE; CORPUS STRIATUM; DOMINANCE, CEREBRAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PSYCHIATRIC STATUS RATING SCALES; RADIOLIGAND ASSAY; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035477930     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00095-5     Document Type: Article

References (31)

1. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort
2. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
3. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs
4. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine
5. 3H]mazindol
6. Change in basal ganglia volume over 2 years in patients with schizophrenia: Typical versus atypical neuroleptics
7. Schizophrenia as failure of hemispheric dominance for language
8. 3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia
9. Structural brain changes in schizophrenia
10. A follow-up magnetic resonance imaging study of schizophrenia
11. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia
12. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients
13. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
14. 3H]GBR 12935 binding sites in human striatal membranes: Binding characteristics and changes in Parkinsonians and schizophrenics
15. Decreased caudate volume in neuroleptic-naive patients
16. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients
17. 18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: Characterization in human subjects
18. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography
19. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
20. 123I]β-CIT
21. Dopaminergic mechanisms in idiopathic and drug-induced psychoses
22. Five-factor model of schizophrenia: Initial validation
23. Five factor model of schizophrenia: Replication across samples
24. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia
25. Neuroleptics and dopamine transporters
26. Elevated dopa decarboxylase activity in living brain of patients with psychosis
27. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake
28. Brain dopamine transporter: Gender differences and effect of chronic haloperidol
29. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task
30. 3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats
31. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism